HTR5A and metabolic dysfunction-associated steatotic liver disease: Moreover, the effects of central 5-HT and its receptor were examined to ascertain their relationship with peripheral 5-HT and the feasibility of serum 5-HT concentration as a biomarker was explored in both mouse models and samples from NAFLD patients.